| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| OCULAR THERAPEUTIX, INC | President and CEO, Director | Common Stock | 589K | $2.86M | $4.86 | Feb 5, 2024 | Direct |
| Aura Biosciences, Inc. | Director | Common Stock | 10.5K | $80.2K | $7.64 | Jun 20, 2024 | Direct |
| OCULAR THERAPEUTIX, INC | President and CEO, Director | Common Stock | 6.5K | $31.6K | $4.86 | Feb 3, 2024 | By Spouse |
| OCULAR THERAPEUTIX, INC | President and CEO, Director | Stock Option (Right to Buy) | 549K | Feb 3, 2024 | Direct | ||
| Aura Biosciences, Inc. | Director | Stock Option (Right to Buy) | 14.5K | Jun 20, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| AURA | Aura Biosciences, Inc. | Jun 20, 2024 | 2 | $0 | 4 | Jun 24, 2024 | Director |
| OCUL | OCULAR THERAPEUTIX, INC | Feb 3, 2024 | 3 | $95.5K | 4 | Feb 6, 2024 | President and CEO, Director |
| OCUL | OCULAR THERAPEUTIX, INC | Jan 31, 2024 | 1 | -$90.8K | 4 | Feb 2, 2024 | President and CEO, Director |
| OCUL | OCULAR THERAPEUTIX, INC | Aug 30, 2023 | 1 | $24.8K | 4 | Sep 5, 2023 | President and CEO, Director |
| AURA | Aura Biosciences, Inc. | Jun 7, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
| OCUL | OCULAR THERAPEUTIX, INC | Feb 6, 2023 | 1 | -$83.4K | 4 | Feb 8, 2023 | President and CEO, Director |
| OCUL | OCULAR THERAPEUTIX, INC | Jan 30, 2023 | 2 | $0 | 4 | Feb 1, 2023 | President and CEO, Director |
| AURA | Aura Biosciences, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
| OCUL | OCULAR THERAPEUTIX, INC | Feb 3, 2022 | 2 | $0 | 4 | Feb 7, 2022 | President and CEO |
| AURA | Aura Biosciences, Inc. | Oct 28, 2021 | 1 | $0 | 4 | Oct 29, 2021 | Director |
| AURA | Aura Biosciences, Inc. | Oct 28, 2021 | 0 | $0 | 3 | Oct 28, 2021 | Director |
| OCUL | OCULAR THERAPEUTIX, INC | Aug 20, 2021 | 1 | $49.5K | 4 | Aug 24, 2021 | President and CEO, Director |